Spinal Fusion Device Market Size

Spinal Fusion Device Market Size

Spinal Fusion Device Market size was valued at over USD 8.35 billion in 2023 and is expected to register 4.6% CAGR from 2024 to 2032 due to the increasing prevalence of spinal disorders, such as degenerative disc disease, spondylolisthesis, and spinal stenosis. As these conditions become more common, the demand for effective treatments including spinal fusion devices is rising.

To get key market trends

  Download Free Sample

Healthcare providers are increasingly adopting these devices to address the growing number of patients with spinal issues. This factor is expected to continue as advancements in medical technology are improving the efficacy and safety of spinal fusion procedures. Moreover, the market will witness expansion with the ongoing need to manage and treat spinal disorders effectively. For instance, in April 2024, WHO reported that over 15 million people globally live with spinal cord injury (SCI). This rising prevalence is underscoring the need for spinal fusion devices which are crucial for effective treatment, rehabilitation, and improving the quality of life for SCI patients.
 

The market is experiencing growth due to continuous technological advancements. Innovations, such as minimally invasive surgical techniques, biologics, and advanced materials like titanium and carbon fiber are enhancing surgical outcomes. These advancements are making spinal fusion procedures safer, more effective, and less invasive, thus attracting more healthcare providers and patients.
 

In the future, the integration of cutting-edge materials and techniques will continue driving the product demand for ensuring better patient outcomes and expanding the adoption of spinal fusion devices globally. For instance, in November 2023, Orthofix Medical Inc. announced the full U.S. commercial launch of the WaveForm® L Lateral Lumbar Interbody System. This 3D-printed spinal fusion device is designed for LLIF procedures and features a porous structure to enhance strength and stability while promoting a robust fusion environment.
 

On the other hand, the higher cost of surgery and devices may deter the product adoption to some degree. Patients are increasingly considering alternative treatments that are more affordable and less invasive. This factor is expected to persist and potentially limit the market growth as cost-effective and non-surgical options are gaining popularity.